Henry Schein (HSIC) Rating Reiterated by Goldman Sachs Group

Henry Schein (NASDAQ:HSIC)‘s stock had its “neutral” rating restated by equities research analysts at Goldman Sachs Group in a note issued to investors on Friday.

A number of other equities research analysts also recently commented on the company. Zacks Investment Research raised Henry Schein from a “hold” rating to a “buy” rating and set a $85.00 target price for the company in a report on Tuesday, July 10th. BidaskClub downgraded Henry Schein from a “buy” rating to a “hold” rating in a report on Friday, July 13th. Stifel Nicolaus lifted their target price on Henry Schein from $76.00 to $81.00 and gave the stock a “hold” rating in a report on Tuesday, August 7th. Robert W. Baird lifted their target price on Henry Schein from $83.00 to $90.00 and gave the stock an “outperform” rating in a report on Tuesday, August 7th. Finally, Craig Hallum lifted their target price on Henry Schein from $83.00 to $96.00 and gave the stock a “buy” rating in a report on Tuesday, August 7th. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $83.83.

Shares of HSIC stock traded down $0.35 during trading hours on Friday, reaching $82.94. 73,866 shares of the company’s stock were exchanged, compared to its average volume of 1,588,877. Henry Schein has a 1 year low of $62.56 and a 1 year high of $90.52. The firm has a market capitalization of $13.24 billion, a price-to-earnings ratio of 23.31, a PEG ratio of 2.49 and a beta of 0.97. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.68 and a current ratio of 1.29.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Monday, August 6th. The company reported $1.04 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.01 by $0.03. Henry Schein had a return on equity of 20.40% and a net margin of 3.15%. The business had revenue of $3.33 billion for the quarter, compared to analyst estimates of $3.31 billion. During the same quarter in the previous year, the firm earned $0.88 earnings per share. The company’s revenue was up 8.7% on a year-over-year basis. As a group, equities analysts forecast that Henry Schein will post 4.12 earnings per share for the current year.

A number of large investors have recently made changes to their positions in the business. Aperio Group LLC lifted its holdings in Henry Schein by 0.9% in the third quarter. Aperio Group LLC now owns 66,209 shares of the company’s stock valued at $5,630,000 after acquiring an additional 621 shares during the period. Bridge Creek Capital Management LLC lifted its holdings in Henry Schein by 2.1% in the third quarter. Bridge Creek Capital Management LLC now owns 34,947 shares of the company’s stock valued at $2,971,000 after acquiring an additional 705 shares during the period. Fuller & Thaler Asset Management Inc. lifted its holdings in Henry Schein by 57.1% in the second quarter. Fuller & Thaler Asset Management Inc. now owns 2,200 shares of the company’s stock valued at $160,000 after acquiring an additional 800 shares during the period. Kalos Management Inc. lifted its holdings in Henry Schein by 6.3% in the second quarter. Kalos Management Inc. now owns 13,615 shares of the company’s stock valued at $988,000 after acquiring an additional 807 shares during the period. Finally, Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its holdings in Henry Schein by 1.8% in the second quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 46,794 shares of the company’s stock valued at $3,399,000 after acquiring an additional 846 shares during the period.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More: Market Capitalization, Large-Caps, Mid-Caps, Small-Caps

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply